Contract Services Ride High As Funding Floods Biopharma
The contract services industry?s success is largely a result of the improved financial environment, rather than an increased acceptance of outsourcing.
Contract Providers Assume Expanded Responsibilities
Contract service providers are playing a more diverse role in drug development.
Supply Chain Security Tops Concerns for Biopharma Raw Materials
Biopharma are looking to reduce risk, increase performance, and optimize productivity in raw material development.
African Biopharma Market Presents Long-term Opportunities
Biopharma companies seeking to leverage opportunities in African market must adopt the right strategy to achieve success.
FDA Strategies Designed to Speed Generic Drug Approvals
A surge in generic drug applications is testing FDA?s ability to reduce the backlog of ANDAs.
Study: CMO Technical Expertise is Not Enough
Sponsors are demanding high levels of professionalism, performance, and effectiveness in managerial areas to accompany CMOs?' technical expertise.
Preparing to Meet Counterfeiting Regulations
An expert discusses how companies should be preparing to meet the requirements of the Drug Supply Chain Security Act, which requires phase-in of requirements to prevent counterfeiting.
